Literature DB >> 30658073

Ivermectin treatment inhibits the replication of Porcine circovirus 2 (PCV2) in vitro and mitigates the impact of viral infection in piglets.

Xinglong Wang1, Changjie Lv2, Xiaojuan Ji2, Bin Wang2, Li Qiu2, Zengqi Yang3.   

Abstract

Porcine circovirus 2 (PCV2) capsid protein (Cap) has a nuclear localization signal (NLS) and can enter the nucleus. In this study, ivermectin, a small-molecule nuclear import inhibitor of proteins was used to determine the role of nuclear localization of Cap on PCV2 replication. Observation by fluorescence microscopy of the intracellular localization of Cap and Cap NLS in cells cultured with ivermectin (50 μg/mL) determined that Cap and Cap NLS were located in the cytoplasm; in contrast, for cells cultured without ivermectin, they accumulated in the cell nucleus. Ivermectin treatment also reduced nuclear transport of Cap derived from PCV2 infection as well as PCV2 replication in PK-15 cells. In addition, lower levels of PCV2 in tissues and sera of piglets treated with ivermectin were detected by qPCR. These results established for the first time that ivermectin has potent antiviral activity towards PCV2 both in vitro and vivo.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ivermectin; Nuclear localization; Piglets; Porcine circovirus

Mesh:

Substances:

Year:  2019        PMID: 30658073     DOI: 10.1016/j.virusres.2019.01.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

Review 1.  A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.

Authors:  Robert T Kinobe; Leigh Owens
Journal:  Fundam Clin Pharmacol       Date:  2021-01-28       Impact factor: 2.748

2.  Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.

Authors:  Khan Sharun; Kuldeep Dhama; Shailesh Kumar Patel; Mamta Pathak; Ruchi Tiwari; Bhoj Raj Singh; Ranjit Sah; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-05-30       Impact factor: 3.944

Review 3.  Current therapeutic applications and pharmacokinetic modulations of ivermectin.

Authors:  Khan Sharun; T S Shyamkumar; V A Aneesha; Kuldeep Dhama; Abhijit Motiram Pawde; Amar Pal
Journal:  Vet World       Date:  2019-08-08

4.  Expression and evaluation of porcine circovirus type 2 capsid protein mediated by recombinant adeno-associated virus 8.

Authors:  Shuang Li; Bo Wang; Shun Jiang; Xiaohui Lan; Yongbo Qiao; Jiaojiao Nie; Yuhe Yin; Yuhua Shi; Wei Kong; Yaming Shan
Journal:  J Vet Sci       Date:  2021-01       Impact factor: 1.672

5.  Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.

Authors:  Hatem Elalfy; Tarek Besheer; Ahmed El-Mesery; Abdel-Hady El-Gilany; Mahmoud Abdel-Aziz Soliman; Ahmed Alhawarey; Mohamed Alegezy; Tamer Elhadidy; Asem A Hewidy; Hossam Zaghloul; Mustafa Ahmed Mohamed Neamatallah; Douaa Raafat; Wafaa M El-Emshaty; Nermin Y Abo El Kheir; Mahmoud El-Bendary
Journal:  J Med Virol       Date:  2021-03-11       Impact factor: 20.693

6.  Electrochemical Detection of Ivermectin Used for the Treatment of COVID-19 with Glutardialdehyde-Modified Glassy Carbon Electrode.

Authors:  Berna Koçak; Yeliz İpek
Journal:  Electrocatalysis (N Y)       Date:  2022-01-05       Impact factor: 2.933

7.  Ivermectin Inhibits the Replication of Usutu Virus In Vitro.

Authors:  Maria Elisabeth Wald; Claudia Claus; Andrea Konrath; Hermann Nieper; Aemero Muluneh; Volker Schmidt; Thomas Wilhelm Vahlenkamp; Michael Sieg
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

8.  Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats.

Authors:  Hamzah A Alghamdi; Mohammed Al-Zharani; Nada H Aljarba; Abdullah A Alghamdi; Abdulrahman A Alghamdi; Badr A Aldahmash; Doaa M Elnagar; Saad Alkahtani
Journal:  Saudi Pharm J       Date:  2022-06-28       Impact factor: 4.562

9.  Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.

Authors:  Fatemeh Heidary; Reza Gharebaghi
Journal:  J Antibiot (Tokyo)       Date:  2020-06-12       Impact factor: 2.649

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.